Oncolytics Biotech Inc (ONCY)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
87,128,000
EV to revenue ratio (TTM)
51.13
EV to ebitda
-1.787
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
0
EBITDA
-37,649,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-211.20%
Return on equity (TTM)
-769.00%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-0.35
Diluted EPS (TTM)
-0.35
Book value
-0.05
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
45.45
PEG ratio
Price to sales ratio (TTM)
58.6
Price to book ratio (TTM)
1,055.04
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
3
Buy
2
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.148